To assess the utility of the novel device, we performed lobectomies in the resected pig lung and VATS in canine models. The device demonstrated sufficient power to stabilize the lungs and provided a clear field of view during surgery, which enabled us to perform VATS lobectomies more easily than conventional stabilizing forceps. Assessment of the dogs' lungs immediately after detaching the suction-based device revealed no complications such as hemorrhage, air leaks, and bullae formation. Pathological examination after 7 days also showed no substantial damage, except for a small impression in the parenchyma and pleura of the surface layer where the device had contacted the lung tissue. Conclusions Although further validation studies in clinical settings are required, our study indicates that the novel lung-stabilizing device has potentially useful applications in VATS procedures.
performance. At present, there are several surgical devices for stabilizing organs that use vacuum systems, including the OCTOPUS™ tissue stabilizer (Medtronic, Minneapolis, MN, USA), the Starfish™ heart positioner (Medtronic, Minneapolis, MN, USA), and the OVALEAD™ ovary stabilizer (Fuji Systems Corp., Tokyo, Japan). However, there are currently no specific devices for lung retraction.
We hypothesized that a suction-based device may have applications for stabilizing lungs during VATS procedures. In this study, we describe a novel lung-stabilizing device for VATS that provides a good surgical field of view without causing lung injury.
Materials and methods

Animals and surgical procedures
Animal experiments were performed on a resected pig lung and canine models to assess the utility and safety of the novel device. The experiments were approved by the Kyoto University Animal Experimentation Committee, and all surgical procedures and euthanasia were performed in accordance with the animal care guidelines stipulated by the National Institutes of Health.
The power of the novel device was assessed using a resected pig lung purchased from a local slaughterhouse. The weight of the lung lobes ranged from 80 to 280 g, and their physical properties were similar to those of a human lung.
Canine models were then used to evaluate the potential application of the device in VATS procedures. A total of seven adult beagle dogs weighing approximately 6.0 to 10.0 kg were used in this study. After premedication with atropine sulfate at 0.03 mg/kg, the dogs were anesthetized with an intramuscular injection of ketamine hydrochloride at 15 mg/kg and xylazine at 7 mg/kg.
The novel device
The OVALEAD™ device is an endoscopic instrument designed to stabilize the ovary, and is equipped with a hemispheric silicon suction cup that is 20 mm in diameter (Fig. 1A) . This device is able to securely hold a 1.0 kg flat plastic board at −300 mmHg.
We first attempted to perform a lobectomy on the resected pig lung using the unmodified device at a negative pressure of −400 mmHg. Next, we modified the device such that it was equipped with three suction cups in one unit to provide more power to grip the lung tissue (Fig. 1B) . There is a 2 mm vacuum port in the center of each suction cup, and 1-mm-diameter tubes are introduced through these ports. These tubes are gathered into a single duct at the joint of the suction cups and the metal shaft. The device with three suction cups was referred to as the "novel device," and was used to perform a lobectomy on the resected pig lung at a negative pressure of −400 mmHg.
Utility assessment of the novel device for canine VATS
We performed eight cases of VATS lower lobectomies on four dogs (both sides of each dog) to assess the utility of the novel device. Four cases were performed using conventional lung forceps, and were designated as the control cases. The remaining four lobectomies were performed using the novel device, and were designated as the experimental cases. The experiments were equally allocated to the left and right sides in both the control and experimental groups.
In all cases, the animals were placed in the left or right decubitus position before two-port VATS lobectomy was performed. A 1.5 cm camera port was created in the tenth intercostal space and a 7 cm utility incision was made in the sixth intercostal space. The novel device was inserted through the 7 cm incision, and surgery was performed via the same incision. If a surgeon had difficulties in performing the operation through these incisions, additional ports were placed as required. All surgeries were performed by two surgeons who alternated their roles (primary surgeon or assistant) for each procedure.
We assessed the following outcome measures to evaluate the utility of the novel device: surgical duration, number of interruptions during surgery, organ damage, and addition of an assist port. Surgical duration was defined as the duration from the insertion of a device into the thoracic cavity until the completion of the lobectomy, and an interruption during surgery was defined as a situation where the scope was removed from the thoracic cavity due to poor visibility.
Lung damage assessment
To assess lung damage, a single 20-mm-diameter suction cup was continuously applied for 1 h to the surfaces of the dogs' lungs in vivo at a negative pressure of either −400 or −540 mmHg at 11 sites; six sites were subjected to a negative pressure of −400 mmHg and five sites were subjected to a negative pressure of −540 mmHg. Negative pressure was measured using an electronic manometer (Copal Electronics Corp., Tokyo, Japan). As a control experiment, lung forceps were similarly applied to the dogs' lungs for one hour at 12 sites. We used a total of five dogs to assess lung damage. Figure 2A shows the actual experimental conditions at −540 mmHg. The lungs were macroscopically examined immediately after detachment and again 7 days later. Lobectomy was performed in each lung after the second examination. The entire resected lobe for each lung was re-inflated with 10% formalin and immersed in the same solution. After fixation, samples were excised, embedded in paraffin, sectioned, and subjected to either hematoxylin-eosin staining (H-E stain) or Elastica-Masson staining (E-M stain). The stained sections were microscopically examined using an optical microscope.
Lung damage was evaluated using the following outcome measures: alveolar deformation, pleural thickening, pleural hemorrhage, parenchymal hemorrhage, and stromal hypertrophy. The degree of alveolar deformation was assessed using an index ranging from Grade 0 to Grade 3. Specifically, Grade 3 involved overall atelectasis (Fig. 3A , B), Grade 2 involved the deformation of deep lung parenchyma (Fig. 3C, D) , Grade 1 involved the deformation of only the superficial lung parenchyma layer adjacent to the pleura (Fig. 4A, B) , and Grade 0 involved no alveolar deformation (Fig. 4C, D) .
The other outcomes (pleural thickening, pleural hemorrhage, parenchymal hemorrhage, and stromal hypertrophy) were each divided into two categories, where a value of 1 indicated the presence of the outcome measure and a value of 0 indicated its absence. Using these assigned numerical values, we calculated the total number of points in each group to represent the aggregate score for lung damage. This scoring method was developed and implemented by two pathologists and three surgeons.
Statistical analysis
The outcome measures were examined using univariate analyses; the fisher's exact test was used for categorical variables, and the t test was used to compare the total number of points for lung damage. In addition, we also divided the cases subjected to the suction-based device into two groups according to the degree of negative pressure (−400 and −540 mmHg), and compared their outcomes. P values (two-sided) less than 0.05 were considered statistically significant. All statistical analyses were performed using JMP software version 11 (SAS Institute Inc. NC, USA). 
Results
Utility assessment of the novel device using the resected pig lung
The utility of the novel device was first assessed ex vivo by conducting lobectomies in the resected pig lung. Initially, we found that the unmodified device lacked the power to grip the heavy lobes of the lung. However, the novel device with three suction cups was able to securely lift up the lung lobes under conditions of −400 mmHg. This would stabilize the lung and provide a clear field of view for surgeons (Video 1).
Utility assessment of the novel device for canine VATS
The novel device was also found to have useful applications in the canine VATS lobectomies (Video 2). The results of the utility outcome measures for these cases are summarized in Table 1 . There were significantly fewer interruptions during surgery in the novel device group than in the lung forceps group. Furthermore, the novel device demonstrated better performance than the lung forceps in the other outcome measures, although the differences were not statistically significant. The use of the novel device contributed to substantially shorter surgical durations (32 vs 22 min), did not result in any intraoperative and postoperative macroscopic damage to the resected lung, and did not require the addition of an assist port.
Lung damage assessment
No complications (such as hemorrhage, air leaks, and bullae formation) were observed under macroscopic examination immediately after detaching the singlesuction cup device for either of the suction conditions (−400 and −540 mmHg for 1 h). Although the device left marks on the lung surface immediately after detachment (Fig. 2B) , these marks generally disappeared after several minutes of ventilation, with the exception of a small amount of congestion (Fig. 2C) . Macroscopic 4 Histologic examination of lung tissue samples 7 days after detachment of the suction-based device. A, B Alveolar deformation and fibroblast formation were limited to the subpleural lung parenchyma, and pleural edema (or thickening) was detected in the area that had been in contact with the suction cup for 1 h at −540 mmHg. The alveolar deformation index was assessed to be Grade 1 in this sample. (A Hematoxylin-eosin stain, magnification ×40; B Elastica-Masson stain, magnification ×40). C, D Pleural thickening with congestion and hemorrhage were observed in the area that had been in contact with the suction cup for 1 h at −400 mmHg. Alveolar deformation and fibroblast formation were not detected, and the alveolar deformation index was assessed to be Grade 0 in this sample. (C Hematoxylin-eosin stain, magnification ×40; D Elastica-Masson stain, magnification ×40) examination conducted 7 days after surgery also revealed that no tissue damage had occurred (Fig. 2D ). Pathological examination of the H-E and E-M stained sections showed several occurrences of alveolar deformation and fibroblast formation in the deep lung parenchyma after being grasped by lung forceps for 1 h (Fig. 3) . In contrast, there was no evidence of alveolar deformation or fibroblast formation in the deep lung parenchyma for lungs subjected to the suction-based device (Fig. 4) ; however, several of these cases showed signs of superficial damage in the lung parenchyma adjacent to the pleura (Fig. 4A, B) that did not penetrate more than 500 μm below the elastic pleural plate.
In all cases, pleural thickening was observed in the areas that were in contact with the suction cup or lung forceps. Based on our scoring method, the degree of deformation in the lung parenchyma was generally lower in the suction-based device cases than in the lung forceps cases. The univariate analysis results of lung damage in the suction-based device cases and lung forceps cases are summarized in Table 2 . A significantly higher incidence of alveolar deformation was detected in the lung forceps group. In addition, stromal hypertrophy was more frequent in the lung forceps group, but this difference was not statistically significant.
The univariate analysis results of lung damage in the two different groups (−400 and −540 mmHg) of suction-based device cases are presented in Table 3 . There were no significant differences between the two groups for all outcome measures.
Discussion
There are currently several suction-based devices for stabilizing organs during surgery, such as the OCTOPUS™ tissue stabilizer, the Starfish™ heart positioner, and the OVALEAD™ ovary stabilizer. The Starfish™ and OCTO-PUS™ devices are used in cardiovascular surgery, and enable off-pump coronary artery bypass grafting to be performed in a safe and efficient manner [1] [2] [3] [4] .
A modified version of the Starfish™ device has been used in minimally invasive cardiac surgery for over a decade. However, there are currently no suction-based stabilizing devices available for general thoracic surgery. A previous case report has described using the Starfish™ device in surgery for mediastinal tumors [5] , but there have been no reports about using these devices for lung surgeries. We considered that it would be difficult to apply these devices in their original form to the fragile lung tissue, and that Table 3 Lung damage assessment of the suctionbased device at −400 and −540 mmHg pressure in canine models CI confidence intervals a P values were calculated using fisher's exact test or t test as appropriate modifications are needed before their application to VATS procedures. During these procedures, surgeons must make frequent and quick changes to lung position, and care must be taken not to damage the organ. We postulated that the OVALEAD™ device may be able to fulfill the criteria needed for VATS procedures. Before evaluation of the novel device, we assessed the unmodified OVALEAD™ in a resected pig lung using a negative pressure of −400 mmHg. However, the device failed to adequately stabilize the lung and was easily detached from the lung surface. As a result, we determined the unmodified device to be underpowered for lung surgery. However, the unmodified device is able to securely hold a 1.0 kg flat plastic board with a single suction cup at −300 mmHg. The unstable attachment between the pig lung and suction cup may therefore have been due to surface moisture, blood, and the softness and flexibility of the lung tissue. Although we first attempted to provide more suction power by increasing the diameter of the suction cup from 20 to 35 mm, this modification proved ineffective as the greater contact area between the suction cup and lung surface was more likely to result in a gap. As an alternate approach, we increased the number of suction cups to achieve adequate power for lung stabilization. We also designed the suction tubes to have thin 1 mm diameters to prevent the simultaneous release of negative pressure between the lung surface and suction cup even if one of the suction cups accidentally detached from the lung. This improvement provided sufficient traction of the lung tissue, which facilitated a clear field of view and allowed surgery to be performed more easily in the canine models.
The use of the novel device in canine VATS made it easier for us to operate on hilar lesions, because the device was able to lift up the lobes and provide an unobstructed view for surgery. This contributed to shorter surgical durations, fewer interruptions in surgery, and a reduction in the need for assist ports. In addition, we did not need to frequently change the lung position during surgery when using the novel device due to the clear field of view that it provided. The number of experiments was relatively small for assessing the novel device. While an increase in the number of animal experiments may strengthen the statistical analysis, our sample size was limited by costs and other practical considerations.
Although we needed to make a 7 cm utility incision to use the novel device in canine experiments due to the flat and small thoracic cavity, a 2.0 cm incision would be sufficient for inserting the novel device if it were folded. We have also further modified the device such that it can be inserted via a 5 mm port. The suction cups and their tubes are first detached from the metal shaft and inserted into the thoracic cavity. In order to reassemble the device within the thoracic cavity, the tubes are pulled using an endoscopic grasper via the 5 mm port and inserted into the lumen of the metal shaft. It is ideal for the suction cup to be vertically attached to the lung surface.
To the best of our knowledge, there are currently no published reports involving the assessment of complications arising from the use of negative pressure on biological tissue. The reasons for using −400 and −540 mmHg as indicators to assess organ damage in this study were that −400 mmHg is the standard pressure for the OCTOPUS™ and Starfish™ devices, and −540 mmHg is the maximum negative pressure that is generally used in the operation room [6] . Our analysis found no significant difference in lung damage between these two levels of negative pressure.
Based on our macroscopic and histologic examination for lung damage, we found that the lung forceps tended to cause irreversible damage such as atelectasis or fibroblast formation. In contrast, the novel device sometimes caused minor alveolar deformation that was limited to the superficial layer of the lung parenchyma. We consider the degree of alveolar deformation after 7 days to be the most important among the outcome measures. This is because areas with alveolar deformation generally exhibit fibrosis or fibroblast formation, which are signs of irreversible damage. We posit that negative pressure is less traumatic for lung tissue than the use of forceps due to the distinctive sponge-like characteristic of lung parenchyma. This characteristic may allow the countertraction of the lung to the suction device to be dispersed and distributed over the entire lobe, thereby minimizing damage to the lung tissue.
We had designed the shape and size of the novel device to accommodate human lungs. In this study, the novel device was found to be useful in VATS procedures in canine models and was able to lift up a resected pig lung lobe, which is similar to the human lung in terms of size and weight. Although this suggests that the novel device may be useful for human patients, further validation studies must be conducted to determine if it has clinical applications. In addition, the device is still a prototype, and may undergo further modifications after clinical studies. As a result, the costs of producing the device remain unclear. Furthermore, improvements in outcomes can reduce the need for postoperative care, which may actually offset production costs. We hope that this novel device can eventually contribute to shorter surgical durations and enable surgeons to perform VATS procedures with increased safety and efficiency.
Conclusions
Although further validation studies in clinical settings are required, our study indicates that the novel lung-stabilizing device may have potentially useful applications in VATS procedures.
